Cargando…

KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription

BACKGROUND: This study aims to clarify the mechanistic action of long non-coding RNA (lncRNA) SNHG12 in the development of renal cell carcinoma (RCC), which may be associated with promoter methylation modification by KMT2B and the regulation of the E2F1/CEP55 axis. METHODS: TCGA and GEO databases we...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jia-fu, Wang, Jun, Xie, Gang, Wang, Yao-dong, Li, Xiao-han, Yang, Wen-yu, Yang, Yu-wei, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123657/
https://www.ncbi.nlm.nih.gov/pubmed/35597996
http://dx.doi.org/10.1186/s12935-022-02607-w
_version_ 1784711597319520256
author Feng, Jia-fu
Wang, Jun
Xie, Gang
Wang, Yao-dong
Li, Xiao-han
Yang, Wen-yu
Yang, Yu-wei
Zhang, Bin
author_facet Feng, Jia-fu
Wang, Jun
Xie, Gang
Wang, Yao-dong
Li, Xiao-han
Yang, Wen-yu
Yang, Yu-wei
Zhang, Bin
author_sort Feng, Jia-fu
collection PubMed
description BACKGROUND: This study aims to clarify the mechanistic action of long non-coding RNA (lncRNA) SNHG12 in the development of renal cell carcinoma (RCC), which may be associated with promoter methylation modification by KMT2B and the regulation of the E2F1/CEP55 axis. METHODS: TCGA and GEO databases were used to predict the involvement of SNHG12 in RCC. Knockdown of SNHG12/E2F1/CEP55 was performed. Next, SNHG12 expression and other mRNAs were quantified by RT-qPCR. Subsequently, CCK-8 was used to detect cell proliferation. Wound healing assay and Transwell assay were used to detect cell migration and invasion, respectively. The in vitro angiogenesis of human umbilical vein endothelial cells (HUVECs) was explored by matrigel-based capillary-like tube formation assay. ChIP assay was used to detect H3K4me3 in SNHG12 promoter region. The binding of E2F1 to CEP55 promoter region was analyzed with ChIP and dual luciferase reporter assays. RIP assay was used to detect the binding of SNHG12 to E2F1. Finally, the effect of SNHG12 on the tumor formation and angiogenesis of RCC was assessed in nude mouse xenograft model. RESULTS: SNHG12 was highly expressed in RCC tissues and cells, and it was related to the poor prognosis of RCC patients. SNHG12 knockdown significantly inhibited RCC cell proliferation, migration, and invasion and HUVEC angiogenesis. KMT2B up-regulated SNHG12 expression through modifying H3K4me3 in its promoter region. In addition, SNHG12 promoted CEP55 expression by recruiting the transcription factor E2F1. Knockdown of SNHG12 blocked E2F1 recruitment and down-regulated the expression of CEP55, thereby inhibiting tumor formation and angiogenesis in nude mice. CONCLUSION: The evidence provided by our study highlighted the involvement of KMT2B in up-regulation of lncRNA as well as the transcription of CEP55, resulting in the promotion of angiogenesis and growth of RCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02607-w.
format Online
Article
Text
id pubmed-9123657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91236572022-05-22 KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription Feng, Jia-fu Wang, Jun Xie, Gang Wang, Yao-dong Li, Xiao-han Yang, Wen-yu Yang, Yu-wei Zhang, Bin Cancer Cell Int Primary Research BACKGROUND: This study aims to clarify the mechanistic action of long non-coding RNA (lncRNA) SNHG12 in the development of renal cell carcinoma (RCC), which may be associated with promoter methylation modification by KMT2B and the regulation of the E2F1/CEP55 axis. METHODS: TCGA and GEO databases were used to predict the involvement of SNHG12 in RCC. Knockdown of SNHG12/E2F1/CEP55 was performed. Next, SNHG12 expression and other mRNAs were quantified by RT-qPCR. Subsequently, CCK-8 was used to detect cell proliferation. Wound healing assay and Transwell assay were used to detect cell migration and invasion, respectively. The in vitro angiogenesis of human umbilical vein endothelial cells (HUVECs) was explored by matrigel-based capillary-like tube formation assay. ChIP assay was used to detect H3K4me3 in SNHG12 promoter region. The binding of E2F1 to CEP55 promoter region was analyzed with ChIP and dual luciferase reporter assays. RIP assay was used to detect the binding of SNHG12 to E2F1. Finally, the effect of SNHG12 on the tumor formation and angiogenesis of RCC was assessed in nude mouse xenograft model. RESULTS: SNHG12 was highly expressed in RCC tissues and cells, and it was related to the poor prognosis of RCC patients. SNHG12 knockdown significantly inhibited RCC cell proliferation, migration, and invasion and HUVEC angiogenesis. KMT2B up-regulated SNHG12 expression through modifying H3K4me3 in its promoter region. In addition, SNHG12 promoted CEP55 expression by recruiting the transcription factor E2F1. Knockdown of SNHG12 blocked E2F1 recruitment and down-regulated the expression of CEP55, thereby inhibiting tumor formation and angiogenesis in nude mice. CONCLUSION: The evidence provided by our study highlighted the involvement of KMT2B in up-regulation of lncRNA as well as the transcription of CEP55, resulting in the promotion of angiogenesis and growth of RCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02607-w. BioMed Central 2022-05-21 /pmc/articles/PMC9123657/ /pubmed/35597996 http://dx.doi.org/10.1186/s12935-022-02607-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Feng, Jia-fu
Wang, Jun
Xie, Gang
Wang, Yao-dong
Li, Xiao-han
Yang, Wen-yu
Yang, Yu-wei
Zhang, Bin
KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title_full KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title_fullStr KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title_full_unstemmed KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title_short KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription
title_sort kmt2b promotes the growth of renal cell carcinoma via upregulation of snhg12 expression and promotion of cep55 transcription
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123657/
https://www.ncbi.nlm.nih.gov/pubmed/35597996
http://dx.doi.org/10.1186/s12935-022-02607-w
work_keys_str_mv AT fengjiafu kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT wangjun kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT xiegang kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT wangyaodong kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT lixiaohan kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT yangwenyu kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT yangyuwei kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription
AT zhangbin kmt2bpromotesthegrowthofrenalcellcarcinomaviaupregulationofsnhg12expressionandpromotionofcep55transcription